How neurons die in Alzheimer's disease: implications for neuroinflammation

A Mangalmurti, JR Lukens - Current opinion in neurobiology, 2022 - Elsevier
Despite the long-standing observation of vast neuronal loss in Alzheimer's disease (AD) our
understanding of how and when neurons are eliminated is incomplete. While previous …

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

Molecular characterization of selectively vulnerable neurons in Alzheimer's disease

K Leng, E Li, R Eser, A Piergies, R Sit, M Tan… - Nature …, 2021 - nature.com
Alzheimer's disease (AD) is characterized by the selective vulnerability of specific neuronal
populations, the molecular signatures of which are largely unknown. To identify and …

Brain atrophy in Alzheimer's disease and aging

L Pini, M Pievani, M Bocchetta, D Altomare… - Ageing research …, 2016 - Elsevier
Thanks to its safety and accessibility, magnetic resonance imaging (MRI) is extensively used
in clinical routine and research field, largely contributing to our understanding of the …

Mnemonic similarity task: A tool for assessing hippocampal integrity

SM Stark, CB Kirwan, CEL Stark - Trends in cognitive sciences, 2019 - cell.com
The hippocampus is critical for learning and memory, relying in part on pattern separation
processes supported by the dentate gyrus (DG) to prevent interference from overlapping …

[HTML][HTML] The impact of sugar consumption on stress driven, emotional and addictive behaviors

A Jacques, N Chaaya, K Beecher, SA Ali… - Neuroscience & …, 2019 - Elsevier
Abstract In 2016 the World Health Organization reported 39% of the world's adult population
(over 18 y) was overweight, with western countries such as Australia and the United States …

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

RJ Bateman, C Xiong, TLS Benzinger… - … England Journal of …, 2012 - Mass Medical Soc
Background The order and magnitude of pathologic processes in Alzheimer's disease are
not well understood, partly because the disease develops over many years. Autosomal …

Neuropathological alterations in Alzheimer disease

A Serrano-Pozo, MP Frosch… - Cold Spring …, 2011 - perspectivesinmedicine.cshlp.org
The neuropathological hallmarks of Alzheimer disease (AD) include “positive” lesions such
as amyloid plaques and cerebral amyloid angiopathy, neurofibrillary tangles, and glial …

The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain

A Gasiorowska, M Wydrych, P Drapich… - Frontiers in aging …, 2021 - frontiersin.org
The elderly population is growing worldwide, with important health and socioeconomic
implications. Clinical and experimental studies on aging have uncovered numerous …

Alzheimer's disease: the challenge of the second century

DM Holtzman, JC Morris, AM Goate - Science translational medicine, 2011 - science.org
Alzheimer's disease (AD) was first described a little more than 100 years ago. It is the most
common cause of dementia with an estimated prevalence of 30 million people worldwide, a …